
From saffron to St John's Wort – scientists reveal the supermarket depression treatments that REALLY work
However, it's becoming increasingly common to try over-the-counter remedies to combat symptoms of depression.
But do these treatments really work?
Dr Rachael Frost, senior lecturer at Liverpool John Moores University, said: "Many of us know someone who struggles with minor or moderate levels of depression, or we may struggle from depressive symptoms ourselves.
"Often, we will try many things to help, such as antidepressants, talking therapies, meditation, or exercise.
"One common treatment people try is OTC products which are widely available and accessible from supermarkets, pharmacies, health food shops, and online.
"Once you start looking into which product might be helpful, the list becomes endless.
"This is particularly the case if you read online blogs or look at social media promotion of various products.
"How do we know what is evidence-based? What products are effective? Are they safe?"
To answer these questions, researchers reviewed studies on 64 different herbal products and dietary supplements available in supermarkets and high street pharmacies.
They had been taken by adults aged 18 to 60 for at least one week across 209 clinical trials.
Evidence was strongest for St John's Wort and saffron, which "often showed effects similar to prescription antidepressants".
Loose Women star opens up about battle with depression saying disorder is 'kicking my a--e and I am so over it'
St John's Wort is a plant which increases the activity of brain chemicals such as serotonin and noradrenaline that are thought to play an important part in regulating our mood.
Saffron is a spice known for its bright yellow-orange colour and distinct flavour. It's popular in curries, risottos and stews.
It was used for decades in traditional Chinese medicine, then pain relief in the 16th to 19th centuries, and now in some cultures for depression.
The trials also suggested that probiotics and vitamin D are more likely to reduce depressive symptoms than a placebo treatment.
Probiotics are thought to help restore the natural balance of bacteria in the gut, while vitamin D helps to regulate the amount of calcium and phosphate in the body.
Scientists also identified 18 products for which there is "emerging evidence".
The most promising were folic acid, lavender, zinc, tryptophan, rhodiola, and lemon balm.
"Further research into these could help determine whether they can help people with depression," Dr Frost said.
Bitter orange, Persian lavender, and chamomile tea also showed positive effects in two trials each.
Some trendy products, such as melatonin, magnesium, and curcumin, showed mixed effects on depression across multiple clinical trials.
Results were also mixed for cinnamon, echium, vitamin C, and a combination of vitamin D plus calcium.
Prebiotics, which support the good bacteria in our gut, and a supplement called SAMe did not seem to be better than a placebo.
The majority of trials looking at omega-3s found it did not affect depression.
Few products presented safety issues, whether used alone or alongside antidepressants.
But the team stressed that patients should speak to their GP before starting any supplements for mental health problems.
Dr Frost said: "It's good news that very few safety concerns arose from any of these products, whether they were taken alone or in combination with antidepressants.
"However, a healthcare professional should always be consulted on whether a product might interact with something else you are taking.
"A higher standard of safety reporting in trials is essential – only 145 (69 per cent) of the examined studies fully reported any side effects from the products.
"Overall, what we have is relatively conclusive evidence for some products.
"Our study has pioneered an exploration into what research is needed to further assess such widely used health care products."
2
Professor Stella Chan, from the University of Reading, who was not involved in the study, added: "It is crucially important for readers to understand that this was a narrative review paper, meaning that it was only a summary of the findings reported from existing research papers.
"These papers would inevitably vary in terms of their scientific quality, including some that might report biased or misleading findings due to limitations such as small sample sizes and poor designs.
"Meta-analyses (that is, analyses that involve combining all existing data into a single dataset) need to be conducted before conclusive statements can be made about the effectiveness of these products.
"Additionally, this review paper excluded studies on individuals with more complicated co-morbid conditions.
"Individuals with more complex mental health needs should be particularly vigilant and avoid making personal health decisions based solely upon narrative review papers."
Depression... the signs to look for and what to do
Depression can manifest in many ways.
We all feel a bit low from time to time.
But depression is persistent and can make a person feel helpless and unable to see a way through.
They may also struggle to about daily life.
Mind says these are some common signs of depression that you may experience:
How you might feel
Down, upset or tearful
Restless, agitated or irritable
Guilty, worthless and down on yourself
Empty and numb
Isolated and unable to relate to other people
Finding no pleasure in life or things you usually enjoy
Angry or frustrated over minor things
A sense of unreality
No self-confidence or self-esteem
Hopeless and despairing
Feeling tired all the time
How you might act
Avoiding social events and activities you usually enjoy
Self-harming or suicidal behaviour
Difficulty speaking, thinking clearly or making decisions
Losing interest in sex
Difficulty remembering or concentrating on things
Using more tobacco, alcohol or other drugs than usual
Difficulty sleeping, or sleeping too much
No appetite and losing weight, or eating more than usual and gaining weight
Physical aches and pains with no obvious physical cause
Moving very slowly, or being restless and agitated
If you feel this way, visit your GP who can help you.
If you, or anyone you know, needs help dealing with mental health problems, the following organisations provide support.
The following are free to contact and confidential:
Samaritans, www.samaritans.org, 116 123, jo@samartiands.org.uk
CALM (the leading movement against suicide in men) www.thecalmzone.net, 0800 585 858
Papyrus (prevention of young suicide) www.papyrus-uk.org, 0800 068 41 41
Shout (for support of all mental health) www.giveusashout.org/get-help/, text 85258 to start a conversation
Mind, www.mind.org, provide information about types of mental health problems and where to get help for them. Email info@mind.org.uk or call the infoline on 0300 123 3393 (UK landline calls are charged at local rates, and charges from mobile phones will vary).
YoungMinds run a free, confidential parents helpline on 0808 802 5544 for parents or carers worried about how a child or young person is feeling or behaving. The website has a chat option too.
Rethink Mental Illness, www.rethink.org, gives advice and information service offers practical advice on a wide range of topics such as The Mental Health Act, social care, welfare benefits, and carers rights. Use its website or call 0300 5000 927 (calls are charged at your local rate).
Depression is increasingly common, to the extent that it is sometimes described as an epidemic.
In the UK, about 11 per cent of people report mild depressive symptoms, four percent consider them moderate, and three per cent say they are severe.
An estimated 8.7million people received antidepressant prescriptions in the UK in 2023/24 - a 2.1 per cent increase on the previous year.
It is unclear exactly how many people take OTC products, but the supplement industry as a whole is said to be worth £3.6billion.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
25 minutes ago
- The Independent
This new SPF from ESPA hydrates, protects and leaves skin naturally radiant with 92% of users agreeing
There's something quietly reassuring about a solid skincare routine, especially when it doesn't require a dozen complicated steps or leave you feeling slick. Still, for many of us SPF is the step that gets forgotten, skipped or reserved for holidays abroad. And who can blame us? Traditional sunscreens can feel chalky, greasy or leave behind a ghostly, stubborn white cast. The thing is: protecting your skin isn't just about beach days. With UV rays, blue light from screens and urban pollution all contributing to premature ageing, SPF really is an everyday essential – whether you're sitting on a sun-drenched patio or just replying to emails indoors. Enter ESPA's new Protect & Brighten Daily Skin Shield SPF 50 (£40, Designed to slot seamlessly into your morning routine, it promises comfortable and lightweight protection, and leaves your skin with a natural luminosity that looks fresh, not filtered. In fact, 92 per cent of users said it gave their skin a visible dewy glow. For those concerned about signs of ageing, or simply wanting to maintain a youthful-looking complexion, this may well be the SPF you've been searching for. So, what makes it stand out in a sea of sun protection? And what's behind these glow-giving claims? Let's take a look. More than sun care Unlike heavy-duty sunscreen sprays that sit on top of the skin, ESPA's Skin Shield is formulated like a luxurious moisturiser that just so happens to include SPF 50. It's powered by hydrating hyaluronic acid, antioxidant-rich beta carotene and Chinese butterfly bush extract, which help to defend against UV rays, blue light and pollution. Together, they offer more than just sun protection: they soothe, hydrate and actively help to reduce the visible signs of ageing. From fine lines to sun spots and uneven tone, the daily aggressors this product guards against are relevant year-round – not just during a heatwave. And because the texture is so lightweight and non-greasy, it layers easily over your existing moisturiser or under make-up (if you're wearing any), without pilling or feeling cakey. A 3-in-1 primer, protector and glow-booster The real beauty of ESPA's Skin Shield lies in its finish. Fast-absorbing and silky, it gives skin a subtle radiance that leaves you looking lit-from-within, naturally and without the strobe effect of a highlighter or shimmer. There's no white cast, no stickiness or even the sensation that you're wearing anything. It's the kind of multi-tasker we look to in the summer months: simplifying your morning routine but sacrificing neither sun protection nor skin smoothing. You can use it as your final skincare step, a smoothing primer or the one thing you slap on if you're running out the door. According to user trials, 96 per cent agreed their skin looked brighter after just two weeks of use and 83 per cent said fine lines and wrinkles appeared softened. For a no-makeup-makeup look, this one's doing the heavy lifting. For all skin types and every kind of day One of the biggest pain points with SPF is inclusivity, and ESPA has paid attention here. Skin Shield is wearable on all tones and textures, from dry and sensitive to oily or blemish-prone. It doesn't clog, flake or fight your base, and it's as comfortable for long hikes as it is for commuting. Add in the fact that you're getting broad-spectrum UVA/UVB coverage and oxidative stress protection in one simple step, and it starts to feel less like a luxury and more like a non-negotiable. Plus, with 20 per cent off (was £50, now £40, it's a timely excuse to elevate your skincare essentials before the seasons shift.


BBC News
25 minutes ago
- BBC News
Shrewsbury cancer charity ready for clinical trials of new drug
A Shropshire charity says it is ready to start clinical trials on a new drug to treat lung the charity Brightwater Research was formed in 2019, its founders have spent 15 years developing the drug Valoxydin, and said the results of initial testing had been manager David Crane said the drug was designed to prevent tumours spreading around the charity is currently seeking funding to fully develop the drug so it can eventually be used to treat patients. Decisions about which medicines are made available on the NHS are made by different organisations in England, Wales and are usuaully based on factors, including the evidence available about a drug and the length by which it could extend patients' from experts and public involvement is also considered. Mr Crane said Valoxydin was an anti-metastatic drug which targeted the formation of secondary tumours – also known as metastases - in the body and stopped the primary cancer from showed the drug could potentially reduce the spread of lung cancer by approximately 80% in animal models, he trustee Ted Youngman, whose father died with lung and brain cancer 15 years ago, said from the initial theory about how the treatment might work, they had begun to experiment with the drug in a petri dish and had gone through more than 50 variations to reach the point it was now at. 'Tremendous' "There's a lot of work still to go, but this is tremendous," Mr Youngman added: "It's much easier to stop [cancer] from spreading than it is to treat it once it's already spread."That's the approach we're taking, which we think is a bit different from other treatments before now."The charity's founders believe it might be possible the drug could be developed for use in the treatment of liver, kidney and bowel cancer, but added a significant amount of additional funding would be needed for further with potential large-scale backers had already begun, Mr Crane said the process could take two to three years, at which point it might be ready for consideration by the drug would be taken as a pill, which would mean it was relatively easy to administer to Crane said the drug would need to be taken daily for the rest of the patient's life – or until another solution is discovered. Follow BBC Shropshire on BBC Sounds, Facebook, X and Instagram.


The Guardian
28 minutes ago
- The Guardian
Was everything brighter 40 years ago? How color perception changes as we age
Every now and then, a bit of nostalgia bait drifts across my social media feed, with people pining for the brighter colors of the past – the vivid hues of the Toys R Us logo, or a 90s McDonald's play zone. On Reddit, posters observe: 'As I get older it feels like life is losing its color,' and ask: 'Were colors brighter and more vibrant when I was younger?' Indeed, according to research from the UK's Science Museum Group, there's been a stark increase in gray everyday objects since the mid-20th century. But this dullification may go beyond the modern preponderance of ashen cars, sad beige nurseries and millennial gray apartments. Scientists believe that color perception itself can fade, altering how the world appears. Depending on how your eyes – and brain – age, the bright red balloon you remember from your seventh birthday party might not look as vivid if you came across it again at 93. Changes in color perception can occur for several reasons. One common factor is structural shifts in the eye. For instance, a cataract – a condition that clouds the eye's lens – can gradually tint vision with a yellow-brown 'brunescent' hue. In the US, about 4m cataract surgeries are performed annually. A brunescent lens 'can pull the blue and green out' of the world around us, says Dr Andrew Iwach of the American Academy of Ophthalmology. After a cataract is removed, the difference in color clarity afterward can be so striking that Iwach wears a bright blue tie to delight his recovering patients. Changes in color perception can also be caused by glaucoma or macular degeneration. Iwach recommends routine eye exams, and says if you notice this type of change, see an ophthalmologist. Research from 2024 found that up to 15% of global dementia cases could be linked to problems with color perception issues, meaning that an eye exam can be an important step in screening and mitigating the disease. Some medications can also affect color perception, says Iwach – namely Viagra (pilots are required to abstain from the drug eight hours before flying lest it affect their perception of blue hues) and some types of heart and tuberculosis medications. Yet research suggests that even in the absence of eye disease or medication use, color perception can shift over the course of our lives. Dr Janneke van Leeuwen, a social neuroscientist and honorary research fellow at University College London's Queen Square Institute of Neurology, noticed a subtle trend in behavioral studies from the last three decades: older adults consistently rated colors duller than younger participants did. Van Leeuwen set out to investigate: do we truly see the world differently as we age? And if so, is it the eyes or the brain driving that change? Her 2023 study involved 17 young adults and 20 older adults in 'an eye tracking experiment' featuring 26 colors, which varied in lightness (how light or dark a color appears) and saturation (how pure and intense a color appears). Using a camera that recorded pupil diameter 1,000 times per second, Van Leeuwen's team observed how participants' pupils reacted to each color. They found a reduction in the way older people's pupils responded to more highly saturated colors, even when correcting for the shrunken baseline pupil sizes that come with age. Thus, it seems some older adults may genuinely perceive the world as less colorful. Van Leeuwen recalls one participant saying: 'Oh, it's a shame there's not a real punchy red.' 'I was thinking: 'Well, you're looking at one!'' she says. The issue, Van Leeuwen explains, 'doesn't necessarily originate in the eyes, but in the brain'. Pupil responses are controlled by the Edinger-Westphal nucleus, a midbrain structure that receives input from the retina and the visual cortex. This means that pupillary reactions reflect both what the eyes detect and how the brain processes that information. Sign up to Well Actually Practical advice, expert insights and answers to your questions about how to live a good life after newsletter promotion The brain becomes less sensitive to how saturated and vivid colors are not because the eyes fail to register them, says Van Leeuwen, but because the visual cortex may no longer interpret them with the same intensity. 'Older adults seem to be particularly less sensitive to the intensity of colors on the magenta-green pathway,' she adds, referring to the anatomical structures in the eye that help process colors. More research is needed to understand why, but the cause probably lies in how the cones in our eyes interact with color-processing pathways in the brain. Currently, Van Leeuwen is following up her study with an investigation into how differences in saturation perception influence the way colors make younger and older adults feel. The 2023 study's findings align with a phenomenon called the Helmholtz-Kohlrausch effect: the brain's tendency to perceive highly saturated colors as brighter than less saturated ones, even if their actual lightness is the same. Believed to be an evolutionary trait for important evaluations such as the ripeness of fruit, this effect also takes place in the primary visual cortex. This 'further supports our findings that the decline in sensitivity in color saturation in healthy ageing originates in the brain, and not the eyes', says Van Leeuwen. There is no sign this loss of saturation perception follows the same process as the onset of certain types of dementia, Van Leeuwen emphasizes – many older adults experience vision declines without developing dementia, which has multiple risk factors. However, the study does provide insight into how our brains change as a result of normal, healthy ageing, which is useful context in the study of neurological disease. Is there anything you can do to stop age-related declines in saturation perception? Researchers don't currently believe that lifestyle habits can meaningfully influence this process. But there's some evidence that the brain can be 'trained' to see the world differently. Anya Hurlbert, a color and vision scientist at Newcastle University, points to a 2020 study involving EnChroma glasses, which feature a saturation-boosting tint to help reduce the effects of some types of color blindness. Participants with red-green color perception deficiencies who wore the glasses reported seeing increased color saturation even after removing them. Alternatively, simply surrounding oneself with more intense colors could help. As Van Leeuwen notes, 'Older adults tend to evaluate more saturated colors more positively than younger adults … which seems to suggest they might need the extra stimulation.' Just another reason to see the new Wes Anderson movie.